Dr. Cathy Eng

2025 Fast Facts: 🔷154,270 will be diagnosed 🔷 19,330 patients < 50 y/o We created a video using @Vidyard discussing the benefit of #colorectalcancer #cancerprevention. embed.vidyard.com/share/n8eturSf… #ColorectalCancerAwarenessMonth @FightCRC @OncoAlert @VUMC_Cancer @VUMCDiscoveries

@JJSingleton1 @VUMCDiscoveries @pinsmechco @Sid423 TY for your support!

@CathyEngMD @VUMCDiscoveries @pinsmechco @Sid423 Love this

Great evening sharing moments with all that came to our Spring gathering of #patientadvocates, #relentless #survivors @VUMCDiscoveries Young Adult Cancers Program @pinsmechco in #Nashville. They are inspiring! @Sid423 #earlyonset #cancer #patientcare

@TheQueenVee @VUMCDiscoveries @pinsmechco @Sid423 TY for your support!

@CathyEngMD @VUMCDiscoveries @pinsmechco @Sid423 Phenomenal!👏👏

@SyedAAhmad5 Congrats!!!

Proud parent moment. Son graduating medical school. Proud of his accomplishments, dedication, incredible work ethic and passion. Love you.

Celebration: Two of my fave graduating @VUMCDiscoveries 🤩residents are the future of #cancercare tomorrow. Dr. Shabnam Eghbali is going to @Hopkins_HemOnc and Dr. Allie Justus will be going to @DukeCancer for fellowship 👏👏👏. I am SO proud of them. #mentorship #cancer

More than a decade of NIH-funded work from the lab of UCSF's Kevan Shokat led up to this breakthrough. He found a way to create drugs against a mutation that appears in 20% of all cancers, including pancreatic, colon, and lung.

Last chance to register! See you Sunday 🌴@drzakoncology @AdventHealthCFL @MiteshBorad @CathyEngMD @TAMISYoda @MarkSoliman

@mfk321 @VautheyMD @UTMDAnderson @VUMCDiscoveries @VUMChealth @jordanberlin5 Yes! So sorry you missed it. I did not get a chance to check my Xaccount again today.

@CathyEngMD @VautheyMD @UTMDAnderson @VUMCDiscoveries @VUMChealth @jordanberlin5 Would this accessible or available online ?

Delighted to have @VautheyMD @UTMDAnderson internationally recognized expert in #surgical #oncology #cancerresearch will be giving @VUMCDiscoveries @VUMChealth Grand Rounds today. #cancer @jordanberlin5

👏👏 @VautheyMD @UTMDAnderson gave a great Grand Rounds on #colorectal #cancer #liver Mets, the role of #biomarkers outcomes and the future of #ctDNA. The best part is he inspired the next generation of #cancerresearch! @Chelsie_Sievers @jordanberlin5

New from @NLCRTnews: A consensus statement on biomarker testing in #NSCLC. Authors compare major guidelines and evaluate how guideline variability impacts clinical recommendations. Available #OpenAccess: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @OncoAlert #LCSM

🧪 Featured in #CancerScope: Real-world data presented at #GI26 suggest GLP-1 receptor agonists may reduce colorectal cancer risk compared with aspirin. Findings were published in the Journal of Clinical Oncology. Learn more ⬇️ acsjournals.onlinelibrary.wiley.com/doi/full/10.10… @OncoAlert

Congratulations to our Cancer Prevention and Epidemiology Section Editor Dr. Christopher Li, named SVP and Director of Public Health Sciences at @fredhutch! In a recent video, he shares the latest developments in the field: youtube.com/watch?v=hMMj2M… @OncoAlert @RamalingamMD

🧬 Metastatic #GastricCancer is no longer “one disease.” A major review in Nature Reviews Clinical Oncology highlights how biomarker-driven oncology is reshaping the field. 🔍 🔹 MSI-H → durable benefit with immunotherapy 🔹 PD-L1 expression guides IO integration in 1L therapy 🔹 HER2-positive disease evolving beyond trastuzumab 🔹 CLDN18.2 emerging as a major therapeutic target 🔹 FGFR2b gaining momentum as a next-generation biomarker ⚡️ New therapeutic platforms are rapidly changing the landscape: • ADCs • Bispecific antibodies • Cellular therapies • Theranostics • ctDNA-guided monitoring 💥 Key challenge: Despite major advances, most patients still develop resistance → highlighting the need for adaptive and biology-driven strategies. 💡 Medical Watch take: The future of gastric cancer will not be defined by chemotherapy backbone alone… 👉 but by dynamic biomarker integration and next-generation targeted therapeutics. 🔗 nature.com/articles/s4157… @myESMO @ASCO @NatureRevClinOnc @YJanjigianMD @SamuelKlempner @CathyEngMD @marklewismd @BenWestphalen @KoheiShitara @FLordick28391 #GIOncology #PrecisionOncology #Immunotherapy #ctDNA #ADCs #OncoTwitter

Jason Collins, the first openly gay NBA player, has died at the age of 47 following battle with glioblastoma (brain tumor).

13-year NBA veteran Jason Collins has died at 47 years old after a battle with Stage 4 glioblastoma. Collins was the first active, openly gay player in NBA history. RIP.

@Aiims1742 @CentralParkWMD @charlesrudin @MSKCancerCenter @rosslevinemd Charlie @charlesrudin is fantastic! I’ve known him since my fellowship at @UChicagoHemOnc . Congratulations 🎊🎈🍾!!!

Congratulations to @charlesrudin the NEW Cancer Center Director at @MSKCancerCenter (just announced a few hours ago!) Happy to be at the NYC corner of the Cancer Center Directors’s dinner in DC. @rosslevinemd

This Mother’s Day, I’m thinking about my mom, and all the lessons she taught me. I'm proud to honor her memory with the Ann Dunham Water Terrace at the Obama Presidential Center.

How an ‘Impossible’ Idea Led to a #PancreaticCancer Breakthrough nytimes.com/2026/05/12/hea… I still remember my conversation with @cjder23 at an @AACR meeting a few years ago - shocked at how well tolerated Daraxonrasib was given all RAS isoforms, including wild type, was shut down.

Honored to step into the role of Section Head for Colorectal Cancer at @MoffittNews Warm congratulations to my colleagues who have been appointed Section Heads for their respective disease sites — truly a strong team moment. Looking forward to driving meaningful progress together for our patients. #MoffittCancerCenter #colorectalcancer